Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - ARATANA THERAPEUTICS, INC. | petx-20161231xex32_2.htm |
| EX-32.1 - EX-32.1 - ARATANA THERAPEUTICS, INC. | petx-20161231xex32_1.htm |
| EX-31.2 - EX-31.2 - ARATANA THERAPEUTICS, INC. | petx-20161231xex31_2.htm |
| EX-31.1 - EX-31.1 - ARATANA THERAPEUTICS, INC. | petx-20161231xex31_1.htm |
| EX-21.1 - EX-21.1 - ARATANA THERAPEUTICS, INC. | petx-20161231xex21_1.htm |
| EX-10.14(C) - EX-10.14(C) - ARATANA THERAPEUTICS, INC. | petx-20161231xex10_14c.htm |
| EX-10.13(C) - EX-10.13(C) - ARATANA THERAPEUTICS, INC. | petx-20161231xex10_13c.htm |
| EX-10.11(B) - EX-10.11(B) - ARATANA THERAPEUTICS, INC. | petx-20161231xex10_11b.htm |
| 10-K - 10-K - ARATANA THERAPEUTICS, INC. | petx-20161231x10k.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S‑8 (File Nos. 333-189687, 333-193472, 333-203003 and 333-210232) and the Registration Statement on Form S-3 (File No. 333-197414) of Aratana Therapeutics, Inc. of our report dated March 14, 2017 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 14, 2017